Back
Day One Biopharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
DAWN
Day One Biopharmaceuticals, Inc.
Last Price:
$10.03
Seasonality Move:
-34.56%
7 Day Trial
ALL ACCESS PASS
$
7
Day One Biopharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Day One Biopharmaceuticals, Inc. has on average historically fallen by 3.7% based on the past 4 years of stock performance.
-
Day One Biopharmaceuticals, Inc. has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Day One Biopharmaceuticals, Inc. Stock Undervalued?The current Day One Biopharmaceuticals, Inc. [DAWN] share price is $10.37. The Score for DAWN is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
DAWN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Day One Biopharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Day One Biopharmaceuticals, Inc. has on average historically fallen by 3.7% based on the past 4 years of stock performance.
Day One Biopharmaceuticals, Inc. Stock Rating
Sell
20
Day One Biopharmaceuticals, Inc. (DAWN)
is a Sell
Is Day One Biopharmaceuticals, Inc. overpriced?
-
Day One Biopharmaceuticals, Inc. has fallen lower in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Day One Biopharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dayonebio.com
52-Week Data
52-Week High:
13.20
52-Week Low:
5.64
Prediction Charts
Market Cap:
1.1B
Price in USD:
10.37
Volume:
1.4M
Beta:
-1.27
Technical Analysis
SMA50:
10.67
SMA100:
9.45
SMA200:
8.12
52-Wk Change:
14.46%
Stock Predictions
-
Is Day One Biopharmaceuticals, Inc. stock public?Yes, Day One Biopharmaceuticals, Inc. is a publicly traded company.
-
What is the Day One Biopharmaceuticals, Inc. stock quote today?The Day One Biopharmaceuticals, Inc. stock price is 10.37 USD today.
-
How to buy Day One Biopharmaceuticals, Inc. stock online?You can buy Day One Biopharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-10 | 11.87 | 11.42 | 11.99 | 11.27 |
| Feb-11 | 11.40 | 11.23 | 11.46 | 10.79 |
| Feb-12 | 11.22 | 11.00 | 11.24 | 10.76 |
| Feb-13 | 11.15 | 11.35 | 11.53 | 11.04 |
| Feb-17 | 11.25 | 11.88 | 11.94 | 11.00 |
| Feb-18 | 11.76 | 11.56 | 12.12 | 11.41 |
| Feb-19 | 11.50 | 12.07 | 12.09 | 11.37 |
| Feb-20 | 11.94 | 11.78 | 12.05 | 11.67 |
| Feb-23 | 11.75 | 11.70 | 11.92 | 11.18 |
| Feb-24 | 11.78 | 12.02 | 12.15 | 11.61 |
| Feb-25 | 10.90 | 10.93 | 11.65 | 10.50 |
| Feb-26 | 10.91 | 10.65 | 10.91 | 10.33 |
| Feb-27 | 10.63 | 10.60 | 10.69 | 10.44 |
| Mar-2 | 10.21 | 10.37 | 10.62 | 10.11 |
Day One Biopharmaceuticals, Inc. Earnings
Day One Biopharmaceuticals, Inc. Earnings Report: Per Share Day One Biopharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Day One Biopharmaceuticals, Inc. Forecast Revenue Growth
Day One Biopharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Day One Biopharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.71 per share.
* Day One Biopharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.